Colorectal cancer: from primary care, to specialty & nuclear medicine

World Health Organisation estimates the global prevalence of cancer at 14 million cases, with an incidence of 10 million and 6.2 million deaths. Colorectal cancer is the third most common cancer worldwide and its incidence increases with increasing industrialization and development of the country. In Europe about 250,000 new cases are diagnosed each year. Colorectal cancer requires a multidisciplinary approach with specialized research teams and optimizing knowledge and technology developments ranging from the primary health care to digestive and nuclear medicine.

Autorentext

FJ García Gómez is specialist in Nuclear Medicine in Hospital Universitario Virgen Macarena (Seville, Spain). L Araque de los Riscos is specialist in Family and Community Medicine in Distrito Sanitario de Málaga y Valle del Guadalhorce (Málaga, Spain). RM Gálvez Fernández is specialist in Digestive System in EPH Costa del Sol (Marbella, Spain).